5
Total investments
3
Early stage
0
Mid stage
1
Late stage
5y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2022
Our mission is simple, to help all cancer patients not only survive cancer, but thrive. For too long it seems the emphasis has been on survival, at any cost. But, it doesnt have to be that way. We are redefining how cancer patients experience treatment by developing affordable, tech-enabled solutions to prevent the most debilitating side effects because we believe unnecessary pain and suffering should not be the price of survival. Our first two products are cooling devices to prevent nerve damage (peripheral neuropathy) and hair loss during chemotherapy.
Investor
Mar 2022
Meet your dedicated team of registered nurses, lactation consultants, doulas, and more. Mahmee delivers a truly comprehensive suite of in-person and virtual maternity support services that adapts to each family’s unique journey. Our offerings include in-person and virtual doula support to prepare for and recover from childbirth, in-person and virtual lactation appointments to address common infant feeding topics, in-home neonatal jaundice phototherapy treatment, and remote blood pressure monitoring for high-risk prenatal and postpartum patients. Every patient gets access to the Mahmee Membership for daily support groups, educational content, and messaging with their care providers in our iOS and Android apps.
Mahmee is on a mission to make the US the best place in the world to give birth. Were committed to improving birth outcomes for Black and Indigenous mothers and infants, and empowering all families with the wraparound support they deserve during the pregnancy and postpartum period.
Founded in 2014, Mahmee brings over a decade of expertise in designing data-driven maternity care solutions and partnering with health systems, hospitals and payers to produce industry-leading clinical outcomes and to reduce disparities in historically underserved communities.
The company is backed by MaC Venture Capital, Muse Capital, the California Health Care Foundation, Goldman Sachs Asset Management, Revolutions Rise of the Rest Seed Fund, Episcopal Health Foundation of Texas, Illumen Capital, Backstage Capital, Serena Williams, Mark Cuban, and others.
Discover how Mahmee is improving maternity healthcare at mahmee.com.
Investor
Mar 2022
House of Puff is revolutionizing cannabis consumption with a mission to make it chic, effortless, and inclusive.
https://houseofpuff.myflodesk.com/xkfj4hr2ut
Investor
Sep 2021
Backpack Healthcare (formerly Youme Healthcare) provides inclusive, accessible, and comprehensive mental healthcare to children, young adults, and their families. We’re committed to bringing the best of mental healthcare to all populations, regardless of their backgrounds, identities, or circumstances.
We’re each carrying an invisible backpack full of our emotions, traumas, and experiences. And sometimes those backpacks can get too heavy for any one person to bear on their own. Backpack Healthcare is here to help lighten the load with therapy and other mental health resources.
Investor
Mar 2021
Hubly Surgical is proud to announce that HUBLY DRILL, the first and only single-use cranial drill with advanced features for safety and efficiency in any setting, complete with Hubly Cranial Access Kit is NOW AVAILABLE FOR SALE
1. Safety
Novel technology for safety
SMART Auto-Stop and cone-shaped drill bit designed to reduce over-plunge + LED Force Indicator that changes color with force, increasing user control.
2. Efficiency
First of its kind features for increased efficiency
Single-use, cordless power design turns intracranial drilling into a one-handed procedure, increasing stability, ease of use, and speed.
3. For Any Setting
Unprecedented value in bedside cranial access
Advanced safety and efficiency features aim to reduce operating room dependence by increasing access at the bedside, thus enhancing care and lowering hospital costs.
Experience · 12 entries
All (12)
Investments (5)
Founder (2)
2025
Limited Partner
Jun 2025
Portfolia is the most powerful community of women and men investing in the companies we want in the world.
Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity.
Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity.
We drive change while creating wealth.
If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
Limited Partner
Mar 2025
How Women Invest is a venture firm, and sister entity to How Women Lead, a professional network of over 24,000 women.
We see that female founders are a force to be reckoned with and are part of an untapped venture capital landscape.
We invest in U.S. based, female-led and female-majority owned companies in most industry sectors.
With 40% of companies founded by women, generating 26% greater returns, and yet only 2% of venture backing, How Women Invest focuses at the intersection of this opportunity to create ecosystem change.
To learn more about the firm: www.howwomeninvest.com and info@howwomeninvest.com.
M&A Strategic Partner (US Markets)
Jan 2025
GrowthPal fuels your inorganic growth engine with laser-focused precision.
Our AI-powered platform matches you with curated "ready-to-transact" companies in just 2 weeks. Skip the endless search and unlock a curated top funnel of ready-to-merge, acquire, or partner targets, and secure exclusive off-the-market deals in record time.
Its like having a dedicated M&A matchmaker on speed!
GrowthPal empowers you to:
- Fast-track strategic growth: Expand to new markets, fill product gaps, or boost market share through targeted acquisitions, roll-ups, bolt-ons, or acqui-hires.
- Invest smarter: Leverage data-driven insights and expert analysis to identify "Ready to Transact" companies perfectly aligned with your goals.
- Close deals faster: Streamline your M&A pipeline with end-to-end solutions, from target identification to seamless deal closure.
Whether youre:
1. A Fortune 500 seeking strategic expansion
2. A mid-sized company eyeing market dominance
3. A high-growth company looking to double your revenue
4. A nimble startup looking for the perfect acqui-hire
GrowthPal is your growth partner, accelerating your M&A journey with targeted matches and data-driven intelligence.
Stop searching, start acquiring.
Get matched with your perfect M&A partner today.
2023
Mentor
Feb 2023
The Founder Institute is the World’s Largest AI-Native Company Builder, where ambitious professionals, solo founders, and first-time entrepreneurs go to turn ideas into funded, AI-powered startups.
Since 2009, our structured methodology, global mentor network, and platform have helped over 8,900 founders across 100+ countries raise more than $2BN in funding.
Whether you’re an employee ready to make the leap, a solo founder with a big idea, or a first-time entrepreneur looking for direction, we provide the AI toolkit, structured sprints, expert feedback, and investor network to take you from Zero to Founder, faster and cheaper than ever before.
And when you’re ready, our venture fund Founder Capital and global investor network are there to write your first check.
2022
Investor
Apr 2022
Our mission is simple, to help all cancer patients not only survive cancer, but thrive. For too long it seems the emphasis has been on survival, at any cost. But, it doesnt have to be that way. We are redefining how cancer patients experience treatment by developing affordable, tech-enabled solutions to prevent the most debilitating side effects because we believe unnecessary pain and suffering should not be the price of survival. Our first two products are cooling devices to prevent nerve damage (peripheral neuropathy) and hair loss during chemotherapy.
Show all 12 entries ↓
Investment activity
2021–2022 · 5 investments
Recent (last 2 years)Earlier
